Retrospective Study of the Survival of Patients Suffering From Hiv-related Progressive Multifocal Leukoencephalopathy (LEMPMAR)
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government.
Read our disclaimer for details.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Layout table for eligibility information
Ages Eligible for Study:
18 Years and older (Adult, Older Adult)
Sexes Eligible for Study:
Accepts Healthy Volunteers:
HIV-infected patients diagnosed with progressive multifocal leukoencephalopathy
HIV infected patients
Diagnosed with progressive multifocal leukoencephalopathy
Minimal follow-up of one year OR patient deceased less than one year after diagnosis
Loss of follow-up within 12 months after diagnosis
Leukoencephalopathy, Progressive Multifocal
Central Nervous System Diseases
Nervous System Diseases
Central Nervous System Viral Diseases
DNA Virus Infections
Slow Virus Diseases
Central Nervous System Infections